Bausch + Lomb (BLCO) Stock: Buy, Sell, or Hold?
BLCO - Bausch + Lomb Corporation
$17.25
-0.30 (-1.71%)
âŧ
5d:
-4.91%
30d:
+2.92%
90d:
+12.82%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When BLCO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: BLCO is fairly priced but lacks strong directional signals. At -2.9% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: BLCO is fairly priced but lacks strong directional signals. At -2.9% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$36.72
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$22.80
24.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLCO is currently trading at $17.25, which is considered fair relative to its 30-day fair value range of $16.81 to $17.69. The stock's valuation (Forward PE: 15.6) is in line with its historical norms (17.0). Remarkably, the market is currently pricing in an annual earnings decline of 2.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BLCO is in a strong uptrend. The price is currently testing key support at $16.94. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BLCO scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $19.04 (+10.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BLCO is in a strong uptrend. The price is currently testing key support at $16.94. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BLCO scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $19.04 (+10.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$16.81 -
$17.69
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.6%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($19.04)
- WARNING: Composite score 50/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$16.81 -
$17.69
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$16.94
Resistance Level
$18.47
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.55
Wall Street Target
$19.04
(+10.4%)
Revenue Growth (YoY)
9.1%
Earnings Growth (YoY)
-88.6%
Profit Margin
-3.2%
Valuation Discount vs History
-2.9% cheaper
PE vs Historical
15.6 vs 17.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.9%
(market-implied from PE analysis)
1-Year Target
$16.75
(-3%)
2-Year Target
$16.26
(-6%)
3-Year Target
$15.79
(-9%)
3-Yr Target (if PE normalizes)
(PE: 16â17)
$17.26
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 37.2%)
$57.83
(+235%)
Base:
(SPY PE: 15.6, Growth: 37.2%)
$44.59
(+159%)
Bear:
(PE: 13.2, Growth: 37.2%)
$37.90
(+120%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.6 to 17.0
Stabilization Target:
$18.86
(+9.3%)
PE Expansion Potential:
+9.3%
Share & Embed Analysis
Last updated: September 12, 2026 11:11 PM ET
Data refreshes hourly during market hours. Next update: 12:11 AM
Data refreshes hourly during market hours. Next update: 12:11 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLCO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 53 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 35 SELL |
|
WST
West Pharmaceutical ServâĻ |
STRONG BUY
13 analysts |
$405 | 63 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$188 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 41 HOLD |
